Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2Phase 1 2Phase NA 1

Status

Completed 120Recruiting 64Unknown 50Terminated 39Active not recruiting 13Not yet recruiting 10Withdrawn 7Suspended 1No longer available 1

Sponsor Class

INDUSTRY 7OTHER 5

Study Type

Interventional 7

Sponsor

Cancer Type

Other solid neoplasm 7

Conditions

Neoplasms 83Carcinoma, Non-Small-Cell Lung 79Breast Neoplasms 71Leukemia, Myeloid, Acute 39Colorectal Neoplasms 37Recurrence 36Prostatic Neoplasms 34Neoplasm Metastasis 30Multiple Myeloma 28Lymphoma 26Pancreatic Neoplasms 25Melanoma 25Lymphoma, Non-Hodgkin 24Lung Neoplasms 24Leukemia, Lymphocytic, Chronic, B-Cell 23Ovarian Neoplasms 22Lymphoma, Follicular 22Carcinoma, Hepatocellular 22Carcinoma, Renal Cell 21Stomach Neoplasms 19Squamous Cell Carcinoma of Head and Neck 19Lymphoma, Large B-Cell, Diffuse 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Myelodysplastic Syndromes 18Leukemia 18Head and Neck Neoplasms 18Urinary Bladder Neoplasms 17Hematologic Neoplasms 14Carcinoma 13Uterine Cervical Neoplasms 12

Interventions

toripalimab 1tislelizumab 1tanespimycin 1sargramostim 1Ipilimumab 1Albumin-Bound Paclitaxel 1AMG 337 14-toluenesulfonamide 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Withdrawn × INDUSTRY × Solid Tumor × Clear all
NCT06145802 2026-04-29

Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (Gynecological Tumors)

Grit Biotechnology

Phase NA Withdrawn
Other solid neoplasm

Solid Tumor

NCT05982522 2026-03-27

IN10018 Combination Therapy in Previously-treated Solid Tumors

InxMed (Shanghai) Co., Ltd.

Phase 1/2 Withdrawn
Other solid neoplasm

Solid Tumor

NCT05284214 2023-09-15

SALIENT

Partner Therapeutics, Inc.

Phase 2 Withdrawn
Other solid neoplasm

Solid Tumor

NCT05165849 2022-05-20

A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors

Genfleet Therapeutics (Shanghai) Inc.

Phase 1/2 Withdrawn
Other solid neoplasm

Solid Tumor

NCT03147976 2019-08-28

QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors

NantPharma, LLC

Phase 2 Withdrawn
Other solid neoplasm

Solid Tumor

NCT00820768 2018-04-11

A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies

Celgene

Phase 1 Withdrawn
Other solid neoplasm

Solid Tumor

NCT03448211 2018-04-05

A Study of PTS for Patients With Solid Tumors

PTS International Inc.

Phase 1 Withdrawn
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡